ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -99.9% | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | – | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | -50.0% | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | -78.9% | 200 | -71.4% | 0.00% | – |
| Q1 2021 | $19,000 | +280.0% | 700 | +250.0% | 0.00% | – |
| Q4 2020 | $5,000 | -28.6% | 200 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | -30.0% | 200 | 0.0% | 0.00% | – |
| Q2 2020 | $10,000 | +66.7% | 200 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | -50.0% | 200 | 0.0% | 0.00% | – |
| Q4 2019 | $12,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $99,609,000 | 22.32% |
| Bellevue Group AG | 5,465,715 | $203,160,000 | 2.81% |
| Rhenman & Partners Asset Management AB | 455,000 | $16,912,000 | 1.50% |
| Endurant Capital Management LP | 135,901 | $5,051,000 | 1.49% |
| Boxer Capital, LLC | 975,000 | $36,241,000 | 1.25% |
| DCF Advisers, LLC | 56,500 | $2,100,000 | 1.07% |
| Pentwater Capital Management LP | 2,169,022 | $80,623,000 | 1.04% |
| Nicholas Investment Partners, LP | 235,855 | $8,767,000 | 0.95% |
| Amia Capital LLP | 20,464 | $761,000 | 0.88% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,717,000 | 0.83% |